首页> 中文期刊> 《中国神经再生研究(英文版)》 >Pharmacological strategies for treating misfolded rhodopsin- associated autosomal dominant retinitis pigmentosa

Pharmacological strategies for treating misfolded rhodopsin- associated autosomal dominant retinitis pigmentosa

         

摘要

Mutations that cause protein misfolding are implicated in conditions such as retinitis pigmentosa(RP),Usher Syndrome,and myocilin associated primary open angle glaucoma.The aggregation and continuous degradation of a highly abundant misfolded protein add proteolytic load of the affected cells.The subtle balance of cellular homeostasis,once disrupted by an overwhelmed proteolytic system,will lead to cell death and tissue degeneration.

著录项

  • 来源
    《中国神经再生研究(英文版)》 |2022年第1期|110-112|共3页
  • 作者

    Yibo Xi; Yuanyuan Chen;

  • 作者单位

    Department of Ophthalmology University of Pittsburgh Pittsburgh PA USA;

    Department of Pharmacology and Chemical Biology University of Pittsburgh Pittsburgh PA USA;

    McGowan Institute of Regenerative Medicine University of Pittsburgh Pittsburgh PA USA;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号